SUMMARY The clinical course of children with IgM rheumatoid-factor-positive chronic arthritis closely resembles that of seropositive rheumatoid disease in adults. The frequency of HLA DR4 is known to be increased in adults with seropositive rheumatoid arthritis, but the first major report on childhood arthritis did not suggest a correlation, though only 8 seropositive cases were included. Fifty-two children with polyarthritis beginning before the age of 16 who persistently carried IgM rheumatoid factor were studied. HLA DR4 was present in 60(1) of these children but was found in only 29 %Yo of 93 patients with seronegative juvenile arthritis and 27 "Y, of a normal adult population. These results suggest immunogenetic similarities in patients with seropositive arthritis irrespective of age of onset.
Only a small proportion of patients with childhood onset arthritis persistently carry IgM rheumatoid factor (RF) . A recent computer analysis of 148 patients with juvenile chronic arthritis (JCA) seen within 3 months of onset showed that 6'% carried IgM, RFE and their disease was characterised by a polyarticular onset progressing rapidily to bony erosions. ' Seropositivity is known to be more common with increasing age of onset, and there is a marked female preponderance in patients affected. 2 The association of HLA DR4 with adult rheumatoid arthritis is well established.:" However. Stastny Patienits. Fifty-two children, 43 girls and 9 boys, whose arthritis began before the age of 16 H0yeraaletal . " in a study of 77 patients found increased DR5 and DR8 in those with a pauciarticular onset but did not divide their group into persisting pauciarticular and progression to polyarthritis. An increase in antigens HLA B27 and B17 has been described in juvenile psoriatic arthritis, and it has been suggested that presence of B17 is associated with mild arthritis. 16 Our results in patients with seropositive childhood arthritis differ from those of Stastny and Fink, who found HLA DR4 in only one of their 8 latex-positive polyarticular patients.6 This low frequency of HLA DR4, compared with 60% in our group, may be entirely due to the small number of patients included, but the factors of race and patient selection must also be considered. All our patients were Caucasian and had persistently positive tests for rheumatoid factor by both latex and sensitised sheep red cell tests; most had been followed up for at least 5 years. We purposely excluded patients with an intermittently weakly positive latex or red cell agglutination test or a single positive result. Our findings and those of H0yeraal et al., " who showed an increased frequency of HLA DR4 in a small group of children with Rose-Waaler-positive polyarthritis, suggest immunogenetic similarities in adults and children with seropositive disease.
The potential severity of seropositive polyarthritis in childhood has been recognised for some time,'7 but only recently has the radiological progression and response to long-acting drug therapy been reported."8 '9 The high incidence of destructive joint disease, arthroplasty, and the need for long-acting antirheumatic drugs in our group highlights the aggressiveness of the disease and contrasts with the natural history of seronegative polyarticular JCA. '7 We sought HLA associations in our patients which might be useful in predicting disease prognosis or response to therapy. The recognised association between HLA DR3 and the development of proteinuria in adults with rheumatoid arthritis treated with gold or penicillamine2t prompted us to examine antigen frequencies in our patients with toxic reactions to these long-acting drugs. Although toxic reactions occurred during one-quarter of the gold courses and one-third of the penicillamine courses, there were insufficient cases of proteinuria or rash to allow significant antigen associations to be demonstrated.
No single antigen was associated with a specific prognosis; in particular the presence of HLA DR4 did not correlate with disease severity as determined by the need for arthroplasty. Homozygosity for DR4 has been reported to be associated with 'extraordinarily severe disease' in adult rheumatoid arthritis.' Two patients in our group, found to be DR4 homozygotes by family typing, suffered particularly severe disease, requiring multiple arthroplasties within 5 years and, in one, replacement of the aortic valve. However, disease of similar severity was present in DR4 heterozygotes and DR4-negative patients.
A further finding of interest from the families studied was the identification of 4 healthy siblings who shared both haplotypes with affected probands. This is in agreement with studies of rheumatoid arthritis and other HLA-linked diseases and suggests that environmental factors and gene loci distant from the major histocompatability complex may contribute to disease susceptibility. This study confirms that arthritis in childhood associated with IgM rheumatoid factor is frequently severe, destructive, and progressive and establishes that there are immunogenetic similarities in patients with seropositive arthritis irrespective of age of onset. 
